DYADIC INTERNATIONAL INC
NASDAQ: DYAI (Dyadic International, Inc.)
Last update: 59 minutes ago0.466
0.00 (0.22%)
| Previous Close | 0.465 |
| Volume | 116,708 |
| Price / Earnings (Forward) | 15.82 |
| Price / Sales | 11.14 |
| Price / Book | 21.01 |
| 52 Weeks Range |
| Profit Margin | -163.94% |
| Operating Margin (TTM) | -507.00% |
| Diluted EPS (TTM) | -0.200 |
| Quarterly Revenue Growth (YOY) | 17.60% |
| Total Debt/Equity (MRQ) | 548.39% |
| Current Ratio (MRQ) | 3.98 |
| Operating Cash Flow (TTM) | -4.81 M |
| Levered Free Cash Flow (TTM) | -3.06 M |
| Return on Assets (TTM) | -34.95% |
| Return on Equity (TTM) | -214.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Dyadic International, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 30.19% |
| % Held by Institutions | 16.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chapin Davis, Inc. | 30 Jun 2026 | 888,004 |
| Apis Capital Advisors, Llc | 30 Jun 2026 | 804,882 |
| Truist Financial Corp | 30 Jun 2026 | 326,200 |
| Marathon Capital Management | 30 Jun 2026 | 110,000 |
| Sage Mountain Advisors Llc | 30 Jun 2026 | 106,564 |
| Hightower Advisors, Llc | 30 Jun 2026 | 79,469 |
| Northern Trust Corp | 30 Jun 2026 | 69,745 |
| Landscape Capital Management, L.L.C. | 30 Jun 2026 | 55,263 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |